About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Houston | 165 Studies

Clinical Trials DepressionHouston

Depression Clinical Trials in Houston

Find 165 clinical trials for depression near Houston, Texas. Connect with research centers in your area.

All Depression trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 165 trials

CompletedEEG Biomarkers for Predicting Response to Antidepressant TherapyThe purpose of this study is to evaluate the potential early EEG predictors of an individual's response to treatment with antidepressant medications.NCT00289523·Los Angeles, California and 9 others TerminatedRandomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDDA Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).NCT06011577·Dothan, Alabama and 35 others

Depression Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedReal-life Effectiveness of Vortioxetine in DepressionWorldwide Major Depressive Disorder (MDD) has significant negative personal, societal and economic consequences.NCT03555136·Dothan, Alabama and 105 others

CompletedEfficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneThe objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who…NCT03738215·Phoenix, Arizona and 124 others

UnknownDIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using AripiprazoleThis is a 12 month, pragmatic trial designed to assess the differences in a digital medicine system (DMS)- ABILIFY MYCITE (Aripiprazole tablets with sensor)- measuring adherence…NCT03881449·Durham, North Carolina and 1 other

CompletedA Long-Term Study of Aripiprazole in Patients With Major Depressive DisorderThis trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in outpatients with major depressive disorder who have experienced an incomplete response to…NCT00095745·Mesa, Arizona and 57 others

CompletedPhase 2b Study of ALTO-100 in MDDThe purpose of this study is to determine efficacy differences between ALTO-100 and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient…NCT05712187·Birmingham, Alabama and 33 others

CompletedSafety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety and tolerability of vortioxetine, once daily (QD), compared with placebo in adults with major depressive disorder.NCT01153009·Beverly Hills, California and 55 others

CompletedA Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderThe purpose of this study is to compare the tolerability and efficacy of different doses of duloxetine in patients with major depressive disorder.NCT00191061·Little Rock, Arkansas and 31 others

CompletedEfficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderThis study will assess efficacy, safety and tolerability of agomelatine (AGO178) 25 mg and 50 mg in patients with Major Depressive Disorder (MDD).NCT00411099·Scottsdale, Arizona and 43 others

CompletedSafety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety and tolerability of vortioxetine, once daily (QD), compared with placebo in adults with major depressive disorder.NCT01179516·Little Rock, Arkansas and 60 others

CompletedEfficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderThis study will assess efficacy, safety and tolerability of agomelatine (AGO178) 25 mg and 50 mg in patients with Major Depressive Disorder (MDD).NCT00411242·Mesa, Arizona and 50 others

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderThis study is to evaluate that (SEROQUEL®) quetiapine sustained-release is efficacious and safe in the treatment of patients with MDD.NCT00321490·Birmingham, Alabama and 33 others

CompletedStudy to Treat Major Depressive Disorder With a New MedicationThis project is designed to examine the neuronal KCNQ2/3 potassium (K+) channel subtype as a novel treatment target for mood disorders through the administration of the…NCT03043560·New York, New York and 1 other

CompletedStudy Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive DisorderThe primary purpose of this study is to test the safety and tolerability of single ascending doses of Desvenlafaxine Succinate Sustained-Release (DVS SR) in both child and…NCT00619619·Little Rock, Arkansas and 8 others

CompletedEmpower: tDCS for Major Depressive Disorder at HomeA two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder…NCT05202119·Houston, Texas and 1 other

CompletedA Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)This study will evaluate the efficacy of ALKS 5461 when administered daily for 4 weeks to adults with Major Depressive Disorder (MDD) and inadequate response to antidepressant…NCT01500200·Tucson, Arizona and 26 others

Enrolling by invitationPhase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003).NCT06605105·Phoenix, Arizona and 48 others

CompletedStudy to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo in participants with MDD on improving symptoms of depression.NCT05203341·Birmingham, Alabama and 40 others

CompletedAdd-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)The purpose of this study is to determine the efficacy and safety of 800 mg MSI-195 in reducing symptoms of depression in Major Depressive Disorder (MDD)patients with inadequate…NCT01912196·Birmingham, Alabama and 34 others

PreviousPage 5 of 9Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia